Compare Stocks

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COT Cotinga Pharmaceuticals Inc. (COT.V)	C$0.04 -41.7%	C$0.03	C$0.02 ▼ C$0.12	C$770K	N/A	20,281 shs	1,000 shs
MTFB MOTIF BIO PLC/S	$0.11	$0.10	$0.08 ▼ $11.50	N/A	N/A	N/A	867,698 shs

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COT Cotinga Pharmaceuticals Inc. (COT.V)	0.00%	0.00%	0.00%	0.00%	0.00%
MTFB MOTIF BIO PLC/S	0.00%	0.00%	0.00%	0.00%	0.00%

A.I. Pioneer Issues Urgent Warning to Americans (Ad)

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

Click here to learn more while there’s still time.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	N/A	C$0.00 per share	17.50	C($0.18) per share	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	-C$0.12	N/A	∞	N/A	N/A	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COT Cotinga Pharmaceuticals Inc. (COT.V)	C$0.24	685.71%	N/A	N/A	N/A
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	0.05	0.01
MTFB MOTIF BIO PLC/S	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A
MTFB MOTIF BIO PLC/S	N/A

Insider Ownership

Company	Insider Ownership
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A
MTFB MOTIF BIO PLC/S	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COT Cotinga Pharmaceuticals Inc. (COT.V)	N/A	21.99 million	N/A	Not Optionable
MTFB MOTIF BIO PLC/S	7	N/A	N/A	Not Optionable

MTFB, BPH, and COT Headlines

Source	Headline
	Rice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulation tmcnet.com - April 12 at 4:46 PM
	RBM17 (F-5) AC labroots.com - February 24 at 6:32 PM
	Small-molecule A485 mobilizes white blood cells on demand msn.com - February 3 at 9:42 PM
	ROBIT PLC’S FINANCIAL INFORMATION AND ANNUAL GENERAL MEETING IN 2024 finance.yahoo.com - November 3 at 11:21 PM
	4GLOBAL plc's (LON:4GBL) Stock Is Going Strong: Have Financials A Role To Play? finance.yahoo.com - August 9 at 4:20 PM
	Is There An Opportunity With Stelrad Group PLC's (LON:SRAD) 44% Undervaluation? finance.yahoo.com - August 2 at 10:41 AM
	DAVA - Endava plc finance.yahoo.com - June 13 at 9:03 PM
	Lacklustre Performance Is Driving NIOX Group Plc's (LON:NIOX) Low P/S finance.yahoo.com - May 25 at 5:59 PM
	Inovyn launches world’s first bio-attributed PVC plasticstoday.com - May 10 at 10:07 AM
	Cushman & Wakefield PLC CWK Stock Quote morningstar.com - April 27 at 6:51 PM
	The Dizzying ‘Mrs. Davis’ Refuses to Settle for Simple Weirdness thedailybeast.com - April 23 at 6:35 PM
	Ineos Styrolution Launches World’s First Fully Bio-Attributed ABS plasticstoday.com - March 16 at 7:23 PM
	Evli Plc: Financial Statements Bulletin January-December 2022 finance.yahoo.com - February 22 at 9:37 AM
	Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2029 marketwatch.com - February 13 at 7:05 AM
	Luciferase Assay Kits Market Trends and Opportunities and Forecast to 2028 with Top Countries Data marketwatch.com - February 13 at 7:05 AM
	Accenture PLC Cl A wsj.com - February 10 at 9:17 PM
	Consti Plc's financial reporting and Annual General Meeting in 2023 finance.yahoo.com - November 16 at 10:44 PM
	International Space Station’s BFF 3D Prints Human Tissue plasticstoday.com - November 4 at 2:28 PM
	Immunoprotein Reagents and Assay Kits Market Research on Present State and Future Growth Prospects of Key Players, Forecast by 2022 To 2028 marketwatch.com - October 20 at 9:47 AM
	The race to native code execution in PLCs: using RCE to uncover Siemens SIMATIC S7-1200/1500 hardcoded cryptographic keys itwire.com - October 14 at 3:22 PM
	At $3m, Bluebird Bio’s new gene therapy is the most expensive drug in the US bostonglobe.com - October 13 at 11:02 PM
	Motif Bio fool.co.uk - October 3 at 1:53 PM
	Antibodies once acted only as protein blockers. Now, scientists are finding new ways to make them protein destroyers endpts.com - September 23 at 9:43 AM
	Bio-Inspired Composite Materials Are Both Stretchy and Tear-Resistant designnews.com - August 22 at 11:49 PM

Company Descriptions

Cotinga Pharmaceuticals Inc. (COT.V)

CVE:COT

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

MOTIF BIO PLC/S

NASDAQ:MTFB

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial